Breaking News

Taiwan Aviation Official Confirms 47 Dead in TransAsia Crash
Tweet TWEET

Sequenom Announces Participation At 31st Annual JP Morgan Healthcare Conference

     Sequenom Announces Participation At 31st Annual JP Morgan Healthcare
                                  Conference

PR Newswire

SAN DIEGO, Jan. 2, 2013

SAN DIEGO, Jan. 2, 2013 /PRNewswire/ --Sequenom, Inc. (NASDAQ: SQNM), a life
sciences company providing innovative diagnostic testing and genetic analysis
solutions, today announced the Company's participation at the upcoming 31^st
Annual JP Morgan Healthcare Conference, to be hosted at the Westin St. Francis
Hotel in San Francisco, CA. 

On Wednesday, January 9th, Chairman and CEO Harry F. Hixson, Jr., Ph.D, and
Ronald M. Lindsay, Ph.D., Director and EVP of Strategic Planning, will present
starting at 11:30 am PT (2:30 pm ET) to provide an overview of and update on
the Company.

The presentation is expected to last approximately 30 minutes and will be
webcast live through the "Investors" section of the Sequenom website at
www.sequenom.com. An audio replay will be available for 30 days following the
initial presentation webcast. 

About Sequenom

Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to
improving healthcare through revolutionary genetic analysis solutions.
Sequenom develops innovative technology, products and diagnostic tests that
target and serve discovery and clinical research, and molecular diagnostics
markets. The company was founded in 1994 and is headquartered in San Diego,
California. Sequenom maintains a Web site at http://www.sequenom.com to which
Sequenom regularly posts copies of its press releases as well as additional
information about Sequenom. Interested persons can subscribe on the Sequenom
Web site to email alerts or RSS feeds that are sent automatically when
Sequenom issues press releases, files its reports with the Securities and
Exchange Commission or posts certain other information to the Web site.

(Logo:http://photos.prnewswire.com/prnh/20040415/SQNMLOGO)

SOURCE Sequenom, Inc.

Website: http://www.sequenom.com
Contact: Marcy Graham, Senior Director, Investor Relations & Corp Comm,
Sequenom, Inc., +1-858-202-9028, mgraham@sequenom.com or Jakob Jakobsen, Media
Contact, Chandler Chicco Agency, +1-310-309-1003,
jjakobsen@chandlerchiccocompanies.com